Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT07159776 Sponsor: Imelda GI Clinical Research Center Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT07159776
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults (male or female) aged 18 or older
  • People who have been diagnosed with Crohn's disease, ulcerative colitis, or unspecified inflammatory bowel disease (IBD) for at least 1 month
  • People who are currently being treated for IBD with either standard or more advanced medications
  • People who have access to an email address
  • People who are willing to do all their grocery shopping at a Colruyt Group store during the study, using a special loyalty card set up by the study team
  • People who are able to independently complete regular online questionnaires
  • People who are able and willing to use a smartphone and an activity tracker (such as a fitness wristband)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who plan to travel overseas for more than 1 month during the 12-month study period, if internet access would not be reliably available during that time
  • People who have previously had their colon surgically removed
  • People who are unable to communicate clearly with the study team or are unable to follow the study requirements
  • People with a serious medical condition that could interfere with readings from a wearable device, such as heart failure, or having a pacemaker or defibrillator
  • People who are already enrolled in, or planning to enrol in, another clinical trial related to IBD that involves an active treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 15 50 56 91

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Imelda GI Clinical Research Center
Registry
ClinicalTrials.gov
Start date
8 September 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Proportion of patients in which a flare can be detected based on passive monitoring data.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov